Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2026-05-12 @ 10:16 PM
Study NCT ID:
NCT06238635
Status:
RECRUITING
Last Update Posted:
2025-10-29
First Post:
2024-01-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dostarlimab and Cobolimab in Advanced Cervical Cancer
Sponsor:
Meghan Shea
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
23-560
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |